The unexplored 5q13 locus: A role in hematopoietic malignancies

Leukemia and Lymphoma

Volumn 30, Issue 5-6, 1998, Pages 443-448

  Castro, Patricia D ^a   Fairman, Jeffery ^a   Nagarajan, Lalitha ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

5q13; AML; MDS; Myeloblastic leukemia; Myelodysplastic syndromes; Physical mapping

Indexed keywords

DNA MARKER;

ACUTE MYELOBLASTIC LEUKEMIA; CHROMOSOME 5Q; CHROMOSOME DELETION 5; CHROMOSOME FRAGILE SITE; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION 5; GENE LOCATION; HUMAN; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW;

EID: 0031851185     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809057556     Document Type: Review

References (34)

1. Estey, E. H., Keating, M. J., Dixon, D. O., Trujillo, J. M., McCredie, K. B. and Freiriech, E. J. (1987). Karyotype is prognostically more important than the FAB system's distinction between myelodysplastic syndrome and acute myelogenous leukemia. Hematologic Pathology, 1, 203-208.
2. Keating, M. J., Cork, A., Broach, Y., Smith, T., Walters, R. S., McCredie, K. B., Trujillo, J. and Freireich, E. J. (1987). Towards a clinically relevant cytogenctic classification of acute myelogenous leukemia. Leukemia Research, 11, 119-133.
3. Kinsler, K. W. and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell, 87(2), 159-170.
4. Mitelman, F. (1994). Chromosome 5. In: Catalog of Chromosome Aberrations in Cancer, Fifth Edition, F. Mitelman (ed.), (Wiley-Liss, New York) pp 681-837.
5. Le Beau, M. M., Espinosa, R. III. Neuman, W. L., Stock, W., Roulston, D., Larson, R. A., Keinanen, M. and Westbrook, C. A. (1993). Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases. Proceedings of the National Academy of Science USA, 90, 5484-5488.
6. Boultwood, J., Fidler, C., Lewis, S., Kelly, S., Sheridan, H., Littlewood, T. J., Buckle, V. J. and Wainscoat, J. S. (1994). Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q- syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint. Genomics, 19, 425-432.
7. Nagarajan, L., Zavadil, J., Claxton, D., Lu, X., Fairman, J., Warrington, J. A., Wasmuth, J. J., Chinault, A. C., Sever, C. E., Slovak, M. L., Willman, C. L. and Deisseroth, A. B. (1994). Consistent loss of the D5S89 locus mapping telomeric to the interleukin gene cluster and centromeric to EGR-1 in patients with 5q- chromosome. Blood, 83, 199-208.
8. Fairman, J., Chumakov, I., Chinault, A. C., Nowell, P. C. and Nagarajan, L. (1995). Physical mapping of the minimal region of loss in 5q- chromosome. Proceedings of the National Academy of Science USA, 92, 7406-7410.
9. Fairman, J., Wang, R. Y., Liang, H., Zhao, L., Saltman, D., Liang, J. C. and Nagarajan, L. (1996). Translocations and deletions of 5q13.1 in myelodysplasia and acute myelogenous leukemia: evidence for a novel critical locus. Blood, 88, 2259-2266.
10. Horrigan, S. K., Westbrook, C. A., Kim, A. H., Banerjee, M., Stock, W. and Larson, R. A. (1996). Polymerase chain reaction-based diagnosis of del(5q) in acute myeloid leukemia and myelodysplastic syndrome identifies a minimal deletion interval. Blood, 88(7), 2665-2670.
11. Zhou, N., Stoffel, A., Wang, P. W., Eisenbart, J. D., Espinosa, R., Larson, R. A. and LeBeau, M. M. (1997). Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map. Proceedings of the National Academy of Science USA, 94, 6948-6953.
12. Pedersen, B. and Jensen, I. M. (1991). Clinical and prognostic implications of chromosome 5q deletions: 96 high resolution studied patients. Leukemia, 5, 566-573.
13. Pedersen, B. (1996). Anatomy of the 5q- deletion: different sex ratios and deleted 5q bands in MDS and AML. Leukemia, 10, 1883-1890.
14. Gogineni, S. K., da Costa, M. and Verma, R. S. (1996). A new translocation, t(5:21)(q13:q22) in acute myelogenous leukemia. Cancer Genetics Cytogenetics, 88, 167-169.
15. Mitelman, F., Nilsson, P. G., Brandt, L., Alimena, G., Gastaldi, R. and Dallapiccola, B. (1981). Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genetics Cytogenetics, 4, 197-214.
16. Roulston, D., Nucifora, G., Dietz-Band, J., Lebeau, M. M. and Rowley, J. D. (1993). Detection of rare 21q22 translocation breakpoints within the AML1 gene in myeloid neoplasms by fluorescence in situ hybridization. Blood, 82, 532a.
17. Kobayashi, H., Montgomery, K. T., Bohlander, S. K., Adra, C. N., Lim, B. L., Kucherlapati, R. S., Donis-Keller, H., Le Beau, M. M. and Rowley, J. D. (1994). Fluorescence in situ hybridization mapping of translocations and deletions involving the short arm of human chromosome 12 in malignant hematologic diseases. Blood, 84(10), 3473-3482.
18. Haglund, U., Juliusson, G., Stellan, B. and Gahrton, G. (1994). Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood, 83, 2637-2645.
19. Whelan, A. J., Watson, M. S., Porter, F. D. and Steiner, R. D. (1995). Klippel-Trenaunay-Weber syndrome associated with a 5:11 balanced translocation. American Journal of Medical Genetics, 59, 492-494.
20. Chen, Z., Rodman, M., Stone, J. F. and Sandberg, A. A. (1994). Identification of complex t(15;17) in APL by FISH. Cancer Genetics Cytogenetics, 72, 73-74.
21. Hirata, J., Umemura, T., Nishimura, J., Sadamura, S., Sato, H. and Nawata, H. (1992). Double t(1;7)(p36;p11) in a megakaryocytic crisis of chronic myelogenous leukemia with variant t(5;9;22). Cancer Genetics Cytogenetics, 65, 107-110.
22. Lai, J-L., Preudhomme, C., Zandecki, M., Flactif, M., Vanrumbeke, M., Lepelley, P., Wattel, E. and Fenaux, P. (1995). Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoiesis and a high incidence of p53 mutations. Leukemia, 9, 370-381.
23. Simonic, I. and Gericke, G. S. (1996). The enigma of common fragile sites. Human Genetics, 97, 524-531.
24. Yunis, J. J. and Soreng, A. L. (1984). Constitutive fragile sites and cancer. Science, 226, 1199-1204.
25. Jones, C., Penny, L., Mattina, T., Yu, S., Baker, E., Voullaire, L., Langdon, W. Y., Sutherland, G. R., Richards, R. I. and Tunnacliffe, A. (1995). Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature, 376, 145-149.
26. Van den Berghe, H., Vermaelen, K., Mecucci, C., Barbieri, D. and Tricot, G. (1985). The 5q- anomaly. Cancer Genetics Cytogenetics, 17, 89-255.
27. Tavassoli, M., Steingrimsdottir, H., Pierce, E., Jiang, X., Alagox, M., Farzaneh, F. and Campbell, I. G. (1996). Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. British Journal of Cancer, 74(1), 115-119.
28. Cunningham, J. M., Shan, A., Wick, M. J., Mcdonnell, S. K., Schaid, D. J., Tester, D. J., Qian, J., Takahaski, S., Jenkins, R. B., Bostwick, D. G. and Thibodeau, S. N. (1996). Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Research, 56, 4475-4482.
29. Wieland, I., Bohm, M., Arden, K. C., Ammermuller, T., Bogatz, S., Viars, C. S. and Rajewsky, M. F. (1996). Allelic deletion mapping on chromosome 5 in human carcinomas. Oncogene, 12(1), 97-102.
30. Tamura, G., Ogasawara, S., Nishizuka, S., Sakata, K., Maesawa, C., Suzuki, Y., Terashima, M., Saito, K. and Satodate, R. (1996). Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Research, 56, 612-615.
31. McCallum, S. J., Wu, W. J. and Cerione, R. A. (1996). Identification of a putative effector for Cdc42Hs with high sequence similarity to the RasGAP-related protein IQGAP1 and a Cdc42Hs binding partner with similarity to IQGAP2. Journal of Biological Chemistry, 271(36), 21732-21737.
32. Otevrel, T. and Stamato, T. D. (1995). Regional localization of the XRCC4 human radiation repair gene. Genomics, 27(1), 211-214.
33. Hobson, G. M., Krahe, R., Garcia, E., Siciliano, M. J. and Funanage, V. L. Regional chromosomal assignments for four members of the MADS domain transcription enhancer factor 2 (MEF2) gene family to human chromosomes 15q26, 19p12, 5q14, and 1q12-q23. Genomics, 29(3), 704-711.
34. Mitsudomi, T., Friedman, E., Gejman, P. V., McCormick, F. and Gazdar, A. F. (1994). Genetic analysis of the catalytic domain of the GAP gene in human lung cancer cell lines. Human Genetics, 93, 27-31.